Getting pharma policy right the Japanese way
This article was originally published in Scrip
Executive Summary
If Japan needed any reassurance that it was pursuing the right policy path, at least in the pharma/biotech area, plenty was forthcoming at the BIO Asia 2015 conference in Tokyo.